Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Naltrexone is a medication that is currently used to treat drug and alcohol addiction.
Guanfacine is a medication that is currently used to manage the withdrawal symptoms in
individuals undergoing opioid detoxification. A combination of these two medications may be
beneficial in reducing heroin use in individuals addicted to heroin. This study will evaluate
the effectiveness of naltrexone and guanfacine, alone and in combination, at reducing heroin
use in heroin addicts.